Darin Lippoldt sold $1.7M of Neurocrine Biosciences (NBIX)

Executed Jun 29, disclosed Jun 30, 1 day later.

Value, as filed

$1.7M

9,800 sh across 2 lots

Executed

Jun 29

the trade date, as filed

Disclosed

Jun 30

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

DL Darin Lippoldt Chief Legal Officer profile →

Darin Lippoldt (Chief Legal Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Neurocrine Biosciences, Inc. (NBIX). The largest single filing was $1.8M of NBIX (10,000 sh × $179.60, as filed), executed Jul 9.

The name

NBIX Neurocrine Biosciences, Inc. NBIX · Healthcare · 59 filings in 24 months ticker →

Healthcare · Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunolog…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Darin Lippoldt in NBIX

NBIXSALE Neurocrine Biosciences, Inc. $1.8M
10,000 sh × $179.60
Exec Jul 9
Filed Jul 13 · 4:27 PM ET NBIXSALE Neurocrine Biosciences, Inc. $699K
4,376 sh × $159.65
Exec Dec 8 2025
Filed Dec 10 2025 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. $255K
2,184 sh across 2 lots
Exec Feb 13 2025
Filed Feb 14 2025 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. $108K
911 sh × $118.25
Exec Feb 10 2025
Filed Feb 12 2025 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. $191K
1,250 sh × $152.91
Exec Jan 31 2025
Filed Feb 4 2025 · 5:30 PM ET